| T-Cell Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 140show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 85 trials (25 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 85 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall_molecule 55 trials (12 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall_molecule 51 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 40 trials (10 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall_molecule 40 trials (15 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall_molecule 40 trials (14 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 39 trials (11 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall_molecule 34 trials (7 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 33 trials (3 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 30 trials (9 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall_molecule 27 trials (4 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 26 trials (6 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 26 trials (1 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | T-Cell Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |